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Diabetes mellitus (DM) is a global health problem. 
According to the International Diabetes Federation, 
424.9 million people suffered from DM in 2017 and 
this number is expected to rise to 628.6 million by 2045 
(http://www.diabetesatlas.org/resources/2017‑atlas.html). 
Although DM can affect every organ in the body, cardiovascular 
disease is a major cause of death and disability in people with 
diabetes.[1‑3] Diabetic patients frequently suffer from systolic 
and diastolic dysfunction.[4‑6] The streptozotocin (STZ)‑induced 
diabetic rat is a widely used experimental model of DM. 
STZ causes damage to the pancreatic β‑cells, which in turn 
leads to a reduction in insulin synthesis and release and a 
consequent rise in blood glucose.[7,8] Abnormalities in a variety 
of haemodynamic indices including stroke volume, ejection 
fraction, cardiac output, rate of pressure development and 
relaxation have been widely demonstrated in the STZ‑induced 
diabetic heart.[9‑12] At the level of the individual ventricular 
myocyte, many studies have demonstrated prolonged 
time course of contraction and relaxation[13,14] and either 
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unaltered or reduced amplitude of shortening.[15,16] These 
alterations in contraction are attributed, at least in part, to 
disturbances in Ca2+ transport.[9,10,14,17] Within the ventricles, 
the electromechanical properties of cardiac myocytes vary 
transmurally and this may be related to the gradients of stress 
and strain experienced in vivo across the ventricular walls. 
Electrophysiological heterogeneity across the ventricular 
wall is a result of differential transmural expression of 
various ion channel proteins that underlie the different 
action potential waveforms observed in epicardial (EPI) 
and endocardial (ENDO) regions.[18‑20] To date, many of 
the single‑cell studies have been performed in ventricular 
myocytes obtained from whole ventricle. Very little is known 
about the regional effects of STZ‑induced diabetes across the 
ventricles. The aim of the current study was to investigate 
the effects of DM after 5–6 months of STZ‑treatment on 
contraction and Ca2+ transport in EPI and ENDO myocytes 
from the left ventricle of rat heart compared to healthy controls.
Methods
Experimental model
Experiments were performed in the STZ‑induced diabetic rat, 
a well‑characterised animal model of DM.[7,8] Diabetes was 
induced in young adult (220–250 g) male Wistar rats with a 
single intraperitoneal injection of STZ (60 mg/kg body weight) 
in citrate buffer. Age‑matched control rats received an 
injection of citrate buffer alone. Body weight, heart weight and 
non‑fasting blood glucose (OneTouch Ultra 2, LifeScan) were 
measured immediately before experiments. Experiments were 
performed in EPI and ENDO myocytes, 5–6 months after STZ 
treatment. Ethical approval for this project was obtained from 
the UAE University Animal Research Ethics Committee and 
experiments were performed in accordance with institutional 
guidelines.
Isolation of ventricular myocytes
Ventricular myocytes were isolated by enzymatic and 
mechanical dispersal techniques according to previously 
described techniques.[21] After rats were euthanised with a 
guillotine hearts were rapidly removed and mounted on a 
Langendorff perfusion system. Hearts were perfused with 
cell isolation solution at a flow rate of  8 ml.g heart–1 min–1 at a 
temperature of 36–37°C. The cell isolation solution contained 
in mmol/l: 130.0 NaCl, 5.4 KCl, 1.4 MgCl2, 0.75 CaCl2, 
0.4 NaH2PO4, 5.0 HEPES, 10.0 glucose, 20.0 taurine and 10.0 
creatine (pH adjusted to 7.3 with NaOH). When contraction of 
the heart had stabilised, perfusion was switched for 4 min to 
Ca2+‑free cell isolation solution containing 0.1 mmol/l EGTA, 
and then for 6 min to cell isolation solution containing 
0.05 mmol/l Ca2+, 0.60 mg/ml Type 1 collagenase (Worthington 
Biochemical Corp, Lakewood, NJ, USA) and 0.075 mg/ml 
Type XIV protease (Sigma, Taufkirchen, Germany). After 
enzyme treatment, the heart was removed from the perfusion 
system and the left ventricle was carefully dissected according 
to previously described techniques.[21] Using fine scissors, 
thin sections were dissected from the outermost layer 
of the left ventricle (EPI) and innermost layer of the left 
ventricle (ENDO). The sections were carefully minced and 
gently shaken in collagenase‑containing isolation solution 
supplemented with 1% BSA. Cells were filtered from this 
solution at 4‑min intervals and resuspended in cell isolation 
solution containing 0.75 mmol/l Ca2+.
Ventricular myocyte shortening
Ventricular myocyte shortening was measured according 
to previously described techniques.[21] Cells were 
superfused (3–5 ml/min) with normal Tyrode containing 
the following in mmol/l: 140.0 NaCl, 5.0 KCl, 1.0 MgCl2, 
10.0 glucose, 5.0 HEPES and 1.8 CaCl2 (pH 7.4). Unloaded 
EPI and ENDO myocyte shortening were recorded using 
a video edge detection system (VED‑114, Crystal Biotech, 
Northborough, MA, USA). Resting cell length, time to 
peak (TPK) shortening, time to half (THALF) relaxation 
and amplitude of shortening (expressed as a % of resting 
cell length) were measured in electrically stimulated (1 Hz) 
myocytes maintained at 35°C–36°C. Data were acquired and 
analysed with Signal Averager software v 6.37 (Cambridge 
Electronic Design, Cambridge, UK).
Intracellular Ca2+
Intracellular (Ca2+) was measured in Fura‑2/AM‑loaded 
myocytes according to previously described techniques.[21] 
Myocytes were alternately illuminated by 340 nm and 380 nm 
light using a monochromator (Cairn Research, Faversham, 
UK) which changed the excitation light every 2 ms. The 
resulting fluorescence, emitted at 510 nm, was recorded by a 
photomultiplier tube and the ratio of the emitted fluorescence 
at the two excitation wavelengths (340/380 ratio) provided 
an index of intracellular Ca2+ concentration. Resting Fura‑2 
ratio, TPK Ca2+ transient, THALF decay of the Ca2+ transient 
and the amplitude of the Ca2+ transient were measured 
in electrically stimulated (1 Hz) myocytes maintained at 
35–36°C. Data were acquired and analysed with Signal 
Averager software v 6.37 (Cambridge Electronic Design, 
Cambridge, UK).
Measurement of sarcoplasmic reticulum Ca2+ transport
Sarcoplasmic reticulum (SR) Ca2+ was assessed using previously 
described techniques.[21] Fura‑2/AM‑loaded myocytes were 
stimulated electrically (1 Hz) and maintained at 35–36°C. 
When the Ca2+ transients had reached a steady state, electrical 
stimulation was paused for 5 s. Caffeine (20 mM) was then 
applied for 10 s using a rapid solution switching device.[22] 
Electrical stimulation was then restarted and the Ca2+ transients 
were allowed to recover to steady state. Fractional release of 
SR Ca2+ was calculated by comparing the amplitude of the 
electrically‑evoked steady state Ca2+ transients with that of the 
caffeine‑evoked Ca2+ transient. Ca2+ refilling of the SR was 
assessed by measuring the rate of recovery of electrically‑evoked 
Ca2+ transients following application of caffeine.
Assessment of myofilament sensitivity to Ca2+
In some cells shortening and Fura‑2 ratio were recorded 
simultaneously as previously described.[23] Myofilament 
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sensitivity to Ca2+ was assessed from phase‑plane diagrams 
of Fura‑2 ratio versus cell length by measuring the gradient 
of the Fura‑2‑cell length trajectory during late relaxation 
of the twitch contraction. The position of the trajectory 
reflects the relative myofilament response to Ca2+ and hence 
can be used as a measure of myofilament sensitivity to 
Ca2+.[24,25]
Statistics
The results were expressed as the mean ± standard error 
of mean of “n” observations. Statistical comparisons were 
performed using the Independent samples t‑test or one‑way 
ANOVA followed by Bonferroni‑corrected t‑tests for multiple 




Body weight and heart weight were reduced, while heart 
weight/body weight and non‑fasting blood glucose were 
increased in STZ‑induced diabetic rats compared to 
age‑matched controls [Table 1].
Ventricular myocyte shortening
Cell width was not significantly (P > 0.05) altered in EPI‑STZ 
compared to EPI‑CON and in ENDO‑STZ compared to 
ENDO‑CON [Figure 1a]. Cell length was significantly (P < 0.05) 
shorter [Figure 1b] and calculated surface area [Figure 1c] 
was significantly (P < 0.05) smaller in EPI‑STZ compared to 
EPI‑CON (n = 20–53 cells from 6 hearts). Typical recordings of 
myocyte shortening in ENDO‑CON and ENDO‑STZ myocytes 
are shown in Figure 2a. TPK shortening was significantly 
prolonged in EPI‑STZ (102.4 ± 4.7 ms) compared to EPI‑CON 
(77.0 ± 1.8 ms) and in ENDO‑STZ (100.2 ± 4.1 ms) compared 
to ENDO‑CON (82.2 ± 2.7 ms) myocytes (n = 33–52 cells from 
13 hearts) [Figure 2b]. THALF relaxation of shortening was 
significantly prolonged in EPI‑STZ (67.0 ± 6.4 ms) compared 
to EPI‑CON (46.5 ± 2.2 ms) and was not significantly altered 
in ENDO‑STZ (56.6 ± 4.4 ms) compared to ENDO‑CON 
(48.4 ± 2.8 ms) myocytes (n = 33–52 cells from 13 hearts) 
[Figure 2c]. Amplitude of shortening was not significantly 
Table 1: General characteristics of streptozotocin‑induced 
diabetic rats compared to controls
Control Streptozotocin
Body weight (g) 433.29±19.46 285.57±10.80**
Heart weight (g) 1.33±0.05 1.17±0.07*
Heart weight/body weight (mg/g) 3.08±0.18 4.07±0.18**
Non‑fasting blood glucose (mg/dl) 89.14±2.83 448.71±11.55**
Data are mean±SEM, n=7 rats, *P<0.05, **P<0.01. SEM: Standard error 
of mean
Figure 1: Cell width (a), cell length (b) and calculated cell surface area (c) in epicardial and endocardial left ventricular myocytes from streptozotocin 
and control rats. Data are mean ± standard error of mean, n = 20–53 cells from 6 hearts
c
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altered in EPI‑STZ compared to EPI‑CON or in ENDO‑STZ 
compared to ENDO‑CON myocytes [n = 33–52 cells from 13 
hearts; Figure 2d].
Intracellular Ca2+ transients
Typical recordings of Ca2+ transients in ENDO‑CON and 
ENDO‑STZ myocytes are shown in Figure 3a. Resting 
Fura‑2 ratio was not significantly altered in EPI‑STZ 
compared to EPI‑CON or in ENDO‑STZ compared 
to ENDO‑CON myocytes (n = 53–59 cells from 11 to 
12 hearts) [Figure 3b]. TPK Ca2+ transient was significantly 
prolonged in EPI‑STZ (62.6 ± 2.0 ms) compared to 
EPI‑CON (53.0 ± 0.8 ms) and in ENDO‑STZ (68.8 ± 1.9 ms) 
compared to ENDO‑CON (59.8 ± 1.4 ms); myocytes TPK 
Ca2+ transient was also significantly prolonged in ENDO‑STZ 
compared to EPI‑STZ and in ENDO‑CON compared to 
EPI‑CON myocytes (n = 53–59 cells from 11 to 12 hearts) 
[Figure 3c]. THALF decay of the Ca2+ transient was not 
significantly altered in EPI‑STZ (210.2 ± 9.1 ms) compared 
to EPI‑CON (190.0 ± 9.6 ms) and was significantly prolonged 
in ENDO‑STZ (210.4 ± 7.0 ms) compared to ENDO‑CON 
(165.3 ± 6.3 ms) myocytes (n = 53–59 cells from 11 to 
12 hearts) [Figure 3d]. Amplitude of the Ca2+ transient was 
not significantly altered in EPI‑STZ compared to EPI‑CON 
or in ENDO‑STZ compared to ENDO‑CON myocytes 
[n = 53–59 cells from 11 to 12 hearts; Figure 3e].
Sarcoplasmic reticulum Ca2+ transport
A typical recording of electrically‑evoked Ca2+ transients 
followed, after a brief pause, by a caffeine‑evoked 
Ca2+ transient, followed by recovery of Ca2+ transients during 
electrical stimulation in an ENDO‑CON myocyte is shown in 
Figure 4a. Amplitude of the electrically‑evoked Ca2+ transient 
was Significantly larger in ENDO‑STZ compared to EPI‑CON 
[Figure 4b], amplitude of the caffeine‑evoked Ca2+ transient 
[Figure 4c] and area under the curve of the caffeine‑evoked 
Ca2+ transient [Figure 4d] were not significantly altered in 
EPI‑STZ compared to EPI‑CON and in ENDO‑STZ compared 
to ENDO‑CON myocytes (n = 16–22 cells from 4 to 6 hearts). 
Fractional release of Ca2+ was not significantly altered in 
EPI‑STZ (0.72 ± 0.04) compared to EPI‑CON (0.69 ± 0.03) 
and was increased in ENDO‑STZ (0.88 ± 0.02) compared 
to ENDO‑CON (0.63 ± 0.07) myocytes. Fractional 
release was also significantly increased in ENDO‑STZ 
compared to EPI‑STZ myocytes (n = 16–22 cells from 4 
to 6 hearts) [Figure 4e]. Amplitude of Ca2+ transient data 
presented in Figure 3e and 4b were acquired in different sets 
of experiments. It was interesting to note that in Figure 3e 
the amplitude of Ca2+ transient was unaltered in EPI‑STZ 
and ENDO‑STZ compared to respective controls however, in 
Figure 4b the amplitude of the Ca2+ transient was significantly 
(P < 0.05) increased in ENDO‑STZ compared to ENDO‑CON 
Figure 2: Typical recordings of shortening in ENDO‑CON and ENDO‑STZ myocytes (a), time to peak shortening (b), time to half relaxation of shortening (c) 
and amplitude of shortening (d) in epicardial and endocardial left ventricular myocytes from streptozotocin and control rats. Data are mean ± standard 
error of mean, n = 33–52 cells from 13 hearts
dc
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Figure 3: Typical recordings of Ca2+ transients in ENDO‑CON and ENDO‑STZ myocytes (a), resting Fura‑2 ratio (b), time to peak Ca2+ transient (c), time 
to half decay of the Ca2+ transient (d) and amplitude of the Ca2+ transient (e) in epicardial and endocardial left ventricular myocytes from streptozotocin 









Figure 4: Typical recording of electrically‑evoked Ca2+ transients and a caffeine‑evoked Ca2+ transient in an ENDO‑CON myocyte (a), amplitude of the 
electrically‑evoked Ca2+ transient (b), amplitude of caffeine‑evoked Ca2+ transient (c), area under the curve of the caffeine‑evoked Ca2+ transient (d), 
fractional release of Ca2+ (e) and recovery of the Ca2+ transient after caffeine application and resumption of electrical stimulation (f). Data are 
mean ± standard error of mean, n = 16–22 cells from 4 to 6 hearts. ES = Electrical stimulation
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myocytes. These results show that in this model of DM there 
may be variability in results between sets of experiments. The 
rate of recovery of the electrically‑evoked Ca2+ transient, 
following application of caffeine, was not significantly 
altered in EPI‑STZ compared to EPI‑CON but was increased 
in ENDO‑STZ compared to ENDO‑CON myocytes 
[n = 16–22 cells from 4 to 6 hearts; Figure 4f].
Myofilament sensitivity to Ca2+
A typical simultaneous recording of shortening and 
Ca2+ transient and of Fura‑2 ratio plotted against cell 
length are shown in Figure 5a. Myofilament sensitivity to 
Ca2+ was not significantly altered in EPI‑STZ compared 
to EPI‑CON or in ENDO‑STZ compared to ENDO‑CON 
[Figure 5b].
dIscussIon
The main findings of this study were as follows: (1) Cell 
length was shorter in EPI‑STZ compared to EPI‑CON; 
(2) TPK shortening was prolonged in EPI‑STZ compared 
to EPI‑CON and in ENDO‑STZ compared to ENDO‑CON; 
(3) THALF relaxation of shortening was prolonged in EPI‑STZ 
compared to EPI‑CON; (4) TPK Ca2+ transient was prolonged 
in EPI‑STZ compared to EPI‑CON, ENDO‑STZ compared 
to ENDO‑CON, ENDO‑STZ compared to EPI‑STZ and in 
ENDO‑CON compared to EPI‑CON; (5) THALF decay of 
the Ca2+ transient was prolonged in ENDO‑STZ compared 
to ENDO‑CON; (6) Fractional release of Ca2+ was increased 
in ENDO‑STZ compared to ENDO‑CON and in ENDO‑STZ 
compared to EPI‑STZ and (7) Ca2+ transient recovery was 
prolonged in ENDO‑STZ compared to ENDO‑CON.
The results show that blood glucose was 5‑fold higher in 
STZ‑induced diabetic rats compared to controls. STZ causes 
damage to β‑cells which in turn leads to a reduction in synthesis 
and release of insulin and consequent elevation of blood 
glucose.[7,8] Consistent with many previous studies STZ rats 
had reduced body weight and reduced heart weight, yet their 
heart weight/body weight ratio was larger compared to controls 
suggesting cardiac hypertrophy.[21,26,27] After 3 months of STZ 
treatment, a previous study has shown that EPI and ENDO 
myocyte lengths were unaltered.[21] However, in the current 
study, after 5–6 months of STZ treatment, the lengths of EPI 
and ENDO myocytes were smaller compared to respective 
controls.
TPK shortening was prolonged, and to similar extents, in 
EPI‑STZ and ENDO‑STZ compared to respective controls. 
THALF relaxation of shortening was prolonged only in 
EPI‑STZ compared to EPI‑CON. Amplitude of shortening 
was not altered in EPI and ENDO myocytes from STZ rat 
compared to controls. Previous studies have also reported 
prolonged TPK in myocytes isolated from whole ventricle 
and EPI and ENDO myocytes after 3 months of STZ 
treatment.[14,21,28,29] Interestingly, THALF relaxation was only 
significantly prolonged in EPI‑STZ compared to EPI‑CON 
myocytes suggesting regional differences in the effects of 
DM on the kinetics of contraction. A previous study reported 
prolonged THALF relaxation in ENDO‑STZ compared to 
ENDO‑CON after 3 months of STZ treatment suggesting that 
the effects on dynamics of contraction alter with duration of 
DM.[21] Although the kinetics of contraction were altered the 
amplitude of contraction was not altered in EPI and ENDO 
myocytes from diabetic rat compared to respective controls 
and this was also previously the case after 3 months of STZ 
treatment.[21]
TPK Ca2+ transient was prolonged in EPI‑STZ compared to 
EPI‑CON and in ENDO‑STZ compared to ENDO‑CON. 
Previous studies in myocytes from whole ventricle have also 
demonstrated prolonged TPK Ca2+ transient in STZ‑induced 
diabetic rat.[26,29‑31] It has also been previously reported that 
after 3 months of STZ treatment TPK Ca2+ transient was 
only prolonged in ENDO‑STZ and not in EPI‑STZ myocytes 
compared to respective controls.[21] It was interesting to note that 
TPK Ca2+ transient was also prolonged in ENDO‑STZ compared 
to EPI‑STZ and in ENDO‑CON compared to EPI‑CON 
suggesting regional differences in kinetics of the Ca2+ transient 
within control and diabetic hearts. THALF decay of the 
Ca2+ transient was only prolonged in ENDO‑STZ compared 
Figure 5: Typical simultaneous recording of shortening and Ca2+ in an ENDO‑CON myocyte (left panel) and typical phase plane diagram of Fura‑2 ratio 
unit versus cell length (right panel) in an ENDO‑CON myocyte. The line and arrow indicate where measurements were made (a), Graph showing mean 
gradient of the Fura‑2‑cell length trajectory during late relaxation of the twitch contraction during the period 500–800 ms (b). Data are mean ± standard 
error of mean, n = 26–29 cells from 5 hearts
ba
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to ENDO‑CON myocytes. Previous studies have demonstrated 
prolonged THALF Ca2+ transient in myocytes from whole 
ventricle and ENDO‑STZ compared to ENDO‑CON myocytes 
after 3 months of STZ treatment.[21,28,32] Although the kinetics 
of the Ca2+ transient were altered the amplitude of contraction 
was not altered in EPI and ENDO myocytes from diabetic rat 
compared to respective controls and this was also previously 
the case after 3 months of STZ treatment.[21]
Fractional release of Ca2+ was increased in ENDO‑STZ 
compared to ENDO‑CON and in ENDO‑STZ compared to 
EPI‑STZ. The fractional release of Ca2+ provides a measure 
of the amount of Ca2+ that is released during electrical 
stimulation compared to the amount that is releasable 
during application of caffeine. The results suggest that the 
fractional release of Ca2+ is larger in ENDO‑STZ and is 
not altered in EPI‑STZ compared to respective controls. 
Previously, it has been reported that after 3 months of STZ 
treatment, fractional release was reduced in EPI‑STZ and 
not altered in ENDO‑STZ compared to respective controls.
[21] These results provide further evidence of changes in 
Ca2+ handling with the duration of DM. The amplitude of 
the caffeine‑evoked Ca2+ transient and area under the curve 
of the caffeine‑evoked Ca2+ transient were not altered in 
EPI and ENDO myocytes from diabetic heart compared to 
respective controls. Suggesting that the changed fractional 
release is more likely to be associated with the generation of 
the electrically‑evoked Ca2+ transient.
Ca2+ transient recovery was prolonged in ENDO‑STZ compared 
to ENDO‑CON. During caffeine application, there was a rapid 
rise in intracellular (Ca2+) as Ca2+ was released from the SR. 
This was followed, under the continued presence of caffeine, 
by a fall in Ca2+ to resting levels, as Ca2+ was extruded from 
the cell, primarily through the Na+/Ca2+ exchanger. When 
caffeine was stopped and electrical stimulation was restarted, 
the L‑Type Ca2+ channels were activated allowing Ca2+ to 
re‑enter the cell and refill the SR. Over several beats, the 
amplitude of the Ca2+ transient was restored. Regional defects 
in L‑Type Ca2+ current, Na+/Ca2+ exchange current or SR 
Ca2+ ATPase activity may underlie the prolonged recovery of 
the Ca2+ transient in ENDO‑STZ myocytes.[33‑36] It has been 
previously reported that there were no alterations in Ca2+ transient 
recovery in EPI and ENDO myocytes from STZ compared to 
respective controls after 3 months of STZ treatment.[21]
Myofilament sensitivity to Ca2+ was unaltered in EPI and 
ENDO myocytes from STZ compared to respective controls. 
Previous studies have also reported no alterations in myofilament 
sensitivity to Ca2+ in myocytes from whole ventricle of 
STZ‑induced diabetic rat.[37] These data suggest that myofilament 
sensitivity is unaltered in the STZ‑induced diabetic rat.
conclusIon
The kinetics of contraction and Ca2+ transient and fractional 
release of Ca2+ from the SR are altered to different extents 
in EPI and ENDO myocytes from STZ‑induced diabetic rat.
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